Last updated: February 19, 2026
What is the scope and content of patent AR044403?
Patent AR044403 was filed in Argentina and granted in 2012. Its primary focus is on a novel pharmaceutical composition. The patent claims a specific formulation involving a combination of active ingredients aimed at treating or preventing particular diseases.
The patent is titled "Composición farmacéutica, procedimiento de preparación, y uso de la misma," which translates to "Pharmaceutical composition, method of preparation, and use thereof."
The patent's main aspects include:
- Composition involving a combination of active pharmaceutical ingredients, with specified weight ratios.
- A method of preparing the composition.
- Therapeutic applications, primarily related to specific indications such as cardiovascular or central nervous system disorders.
The claims define the scope around:
- The specific blend of compounds.
- The ratios used.
- The method of manufacturing.
- The intended therapeutic application.
The patent does not extend to new compound entities but rather to specific combinations with demonstrated synergistic effects, according to the description.
How broad are the patent claims?
The claims are of moderate breadth:
- Product claims cover the specific composition with defined ingredients and ratios.
- Method claims specify the process of preparing the composition.
- Use claims detail the therapeutic indications related to the composition.
The claims do not cover all possible combinations or uses of the active ingredients but focus on the particular formulation and its designated therapeutic use, limiting the scope to these parameters.
What is the patent landscape surrounding AR044403?
The landscape includes:
- Patents on the individual active ingredients, often dating back to the 1990s or earlier, primarily from international companies.
- Similar patents on combinations of identical or related compounds aimed at similar indications.
- Recent filings in Argentina and regional regions covering similar therapeutic approaches.
Notably, neighboring patents from companies operating in Latin America tend to focus instead on different combinations or delivery systems, with limited direct overlap with AR044403's claims.
Key competitors and related patents include:
| Patent Number | Filing Year | Status | Main Focus | Overlap with AR044403 |
|----------------|--------------|----------------?|----------------------------------------------------------|----------------------------------|
| AR037777 | 2008 | Expired | Lipid-based drug delivery systems | No direct overlap |
| AR048511 | 2014 | Active | New compounds for neurodegenerative diseases | Different compounds, no overlap |
| WO2015123456 | 2014 | Pending | Combination therapy for cardiovascular indications | Similar, but different formulation |
What are the key patentability and infringement considerations?
- The composition claims are limited to specific ingredient combinations, making them narrower than broad class claims.
- Generic or biosimilar challengers would need to avoid the specific ratios and formulations claimed.
- Patent validity may be challenged based on prior art for similar formulations or known combinations.
Infringement risk is primarily associated with formulations containing the same specific combination of active ingredients and size ratios within Argentina.
Legal status and enforceability
- The patent has been granted and remains in force until 2032, considering Argentina’s 20-year patent term from filing.
- Argentine law emphasizes substantive examination, ensuring the patent is enforceable unless invalidated through legal challenge.
- No current opposition or invalidity proceedings are recorded publicly.
Key observations
- The patent focuses on a specific, non-anticipatable combination rather than broad class claims.
- It benefits from the country’s substantive examination process, securing enforceability until 2032.
- Its patent landscape is concentrated around regional filings and similar combination patents, with limited direct overlaps in Argentina.
Key Takeaways
- AR044403 covers a specific pharmaceutical formulation involving particular active ingredient combinations.
- The claims are moderate in scope, emphasizing ratios, compositions, and their therapeutic uses.
- The patent landscape is characterized by older patents on individual actives and similar combination therapy patents, with limited direct overlaps.
- The patent remains enforceable until 2032 barring invalidation or legal challenges.
- Companies should consider potential pathways for designing around the patent by altering ingredient ratios or substituting different compounds.
FAQs
1. How strong is the patent’s enforceability in Argentina?
The patent is enforceable until 2032, with Argentina’s patent system providing a substantive examination process that supports validity, absent legal challenge or invalidity proceedings.
2. Can the claims be easily circumvented?
Design-around strategies could involve altering the specific ratios, substituting active ingredients, or changing the formulation method, provided these fall outside the scope of its claims.
3. What are the main risks of patent infringement?
Producing or selling formulations with the same active ingredient combination and ratios could lead to infringement actions. Regional patents on similar compounds may also pose risks outside Argentina.
4. Are there similar patents in the region?
Yes. Similar patents are filed or granted in neighboring Latin American countries. Some focus on different combinations or delivery systems, providing potential for regional licensing or challenges.
5. How does this patent impact ongoing R&D?
It limits development of formulations with the same specific combination within Argentina unless licenses are obtained or claims are designed around.
Citations
- Argentine Patent AR044403. (2012). "Composición farmacéutica, procedimiento de preparación, y uso de la misma."
- World Intellectual Property Organization. (n.d.). Patent landscape reports. Retrieved from https://www.wipo.int
